Loading data
ENPHNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1.47 bn USD | 1.33 bn USD | 2.29 bn USD | 2.33 bn USD | 1.38 bn USD |
| Cost of revenue | 785.98 m USD | 701.25 m USD | 1.23 bn USD | 1.36 bn USD | 827.63 m USD |
| Gross profit | 687 m USD | 629.14 m USD | 1.06 bn USD | 974.6 m USD | 554.42 m USD |
| Research and development expense | 189.08 m USD | 201.32 m USD | 227.34 m USD | 168.85 m USD | 105.53 m USD |
| Operating profit | 157.53 m USD | 77.29 m USD | 445.74 m USD | 448.26 m USD | 215.83 m USD |
| Interest expense | — | — | 8.84 m USD | 9.44 m USD | 45.15 m USD |
| Profit before tax | 204.81 m USD | 120.16 m USD | 513.14 m USD | 452.05 m USD | 120.93 m USD |
| Income tax expense | 32.68 m USD | 17.5 m USD | 74.2 m USD | 54.69 m USD | -24.52 m USD |
| Net income (reported basis) | 172.1 m USD | 102.7 m USD | 438.9 m USD | 397.4 m USD | 145.4 m USD |
| Basic earnings per share | 1.31 USD/share | 0.76 USD/share | 3.22 USD/share | 2.94 USD/share | — |
| Diluted earnings per share | 1.29 USD/share | 0.75 USD/share | 3.08 USD/share | 2.77 USD/share | — |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.